nach oben

The European Journal of Health Economics

Erschienen in:

25.06.2024 | Commentary

Letter to the Editor: Lazzaro responds to Kennedy et al.

verfasst von: Carlo Lazzaro

Erschienen in: The European Journal of Health Economics | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Auszug

Sirs, …

Kennedy, K., Sarohia, G., Podbielski, D., Pickard, S., Tarride, J.E., Xie, F.: Systematic methodological review of health state values in glaucoma cost-utility analyses. Eur. J. Health Econ. (2024). https://doi.org/10.1007/s10198-023-01663-xCrossRefPubMed

Annemans, L., Genesté, B., Jolain, B.: Early modelling for assessing health and economic outcomes of drug therapy. Value Health. 3, 427–434 (2000). https://doi.org/10.1046/j.1524-4733.2000.36007.xCrossRefPubMed

IJzerman, M.J., Koffijberg, H., Fenwick, E., Krahn, M.: Emerging use of early health technology assessment in medical product development: A scoping review of the literature. Pharmacoeconomics. 35, 727–740 (2017). https://doi.org/10.1007/s40273-017-0509-1CrossRefPubMedPubMedCentral

Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L., Torrance, G.W.: Methods for the Economic Evaluation of Health care Programmes, 4th edn. Oxford University Press, Oxford (2015)

Neumann, P.J., Sanders, G.D., Russell, L.B., Siegel, J.E., Ganiats, T.G. (eds.): Cost-effectiveness in Health and Medicine, 2nd edn. Oxford University Press, New York (2016)

Lazzaro, C., van Steen, C., Billeit, S., Frauenknecht, H., Kallen, C., Pfennigsdorf, S., Thelen, U., Angelillo, L.: Cost-utility analysis of a latanoprost cationic emulsion (STN1013001) versus other latanoprost in the treatment of open-angle glaucoma or ocular hypertension and concomitant ocular surface disease in Germany. Clin. Ophthalmol. 16, 323–337 (2022). https://doi.org/10.2147/OPTH.S351013CrossRefPubMedPubMedCentral

Lazzaro, C., van Steen, C., Aptel, F., Schweitzer, C., Angelillo, L.: Cost-utility analysis of STN1013001, a latanoprost cationic emulsion, versus other latanoprost formulations (latanoprost) in open-angle glaucoma or ocular hypertension and ocular surface disease in France. J. Ophthalmol. (2022). https://doi.org/10.1155/2022/3837471CrossRefPubMedPubMedCentral

Patel, V., Ahmed, I., Podbielski, D., Falvey, H., Murray, J., Goeree, R.: Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. J. Med. Econ. 22(4), 390–401 (2019). https://doi.org/10.1080/13696998.2019.1572013CrossRefPubMed

Ordóñez, J.E., Ordóñez, A., Osorio, U.M.: Cost-effectiveness analysis of iStent trabecular micro-bypass stent for patients with open-angle glaucoma in Colombia. Curr. Med. Res. Opin. 35(2), 329–340 (2019). https://doi.org/10.1080/03007995.2018.1506022CrossRefPubMed

10.

van Gestel, A., Webers, C.A., Severens, J.L., Beckers, H.J., Jansonius, N.M., Hendrikse, F., Schouten, J.S.: The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma. Acta Ophthalmol. 90, 20–31 (2012). https://doi.org/10.1111/j.1755-3768.2011.02318.xCrossRefPubMed

11.

O’Hagan, A., Buck, C.E., Daneshkhah, A., Eiser, J.R., Garthwaite, P.H., Jenkinson, D.J., Oakley, J.E., Rakow, R.: Uncertain Judgements: Eliciting Experts’ Probabilities. Wiley, Chichester (2006)CrossRef

12.

McAteer, H., Cosh, E., Freeman, G., Pandit, A., Wood, P., Lilford, R.: Cost-effectiveness analysis at the development phase of a potential health technology: Examples based on tissue engineering of bladder and urethra. J. Tissue Eng. Regen Med. 1, 343–349 (2007). https://doi.org/10.1002/term.36CrossRefPubMed

13.

Girling, A., Young, T., Brown, C., Lilford, R.: Early-stage valuation of medical devices: The role of developmental uncertainty. Value Health. 13, 585–591 (2010). https://doi.org/10.1111/j.1524-4733.2010.00726.xCrossRefPubMed

Titel: Letter to the Editor: Lazzaro responds to Kennedy et al.
verfasst von: Carlo Lazzaro
Publikationsdatum: 25.06.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: The European Journal of Health Economics / Ausgabe 1/2025
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-024-01703-0

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system

Original Paper

Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care

Open Access
Original Paper

Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO)

Open Access
Original Paper

Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes

Open Access
Original Paper

Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden

Open Access
Original Paper

Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial

Open Access
Original Paper

Springer Medizin

Letter to the Editor: Lazzaro responds to Kennedy et al.

Auszug

Weitere Artikel der Ausgabe 1/2025

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system

Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care

Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO)

Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes

Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden

Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system

Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care

Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO)

Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes

Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden

Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial